XML 18 R14.htm IDEA: XBRL DOCUMENT v2.3.0.15
Derivative Instruments
9 Months Ended
Sep. 30, 2010
Derivative Instruments and Hedging Activities Disclosure [Abstract] 
Derivative Instruments and Hedging Activities Disclosure [Text Block]
Derivative Instruments
The Company uses derivative instruments that are not designated as hedges under FASB accounting guidance related to the accounting for derivative instruments and hedging activity, to hedge the fluctuations in foreign exchange rates for recognized balance sheet items such as intercompany receivables. As of September 30, 2011, the Company has in place foreign currency hedge contracts maturing March 2012 with a notional value totaling $22.0 million. The intended purpose of these hedging instruments is to offset the income statement impact of recorded foreign exchange transaction gains and losses resulting from U.S. dollar denominated intercompany invoices issued by our Indian subsidiary whose functional currency is the Indian rupee. The change in the fair value of these derivatives was recorded in foreign currency exchange gains (losses) in the Condensed Consolidated Statements of Income and was $(1.1) million and $1.3 million for the nine months ended September 30, 2011 and 2010, respectively. These losses (gains) are in addition to the consolidated foreign exchange gains (losses) equivalent to $3.7 million and $(401) thousand recorded during the nine months ended September 30, 2011 and 2010, respectively, incurred by our subsidiaries for settlement of transactions denominated in other than their functional currency. As of September 30, 2011, the aggregate fair value of these derivative instruments, which are included in other current liabilities, in the Condensed Consolidated Balance Sheet was $909 thousand. The Company has classified its foreign currency hedges, for which the fair value is remeasured on a recurring basis at each reporting date, as a Level 2 instrument (i.e. wherein fair value is determined and based on observable inputs other than quoted market prices), which we believe is the most appropriate level within the fair value hierarchy based on the inputs used to determine its the fair value at the measurement date.
In connection with the acquisition of E-Z Data effective October 1, 2009, Ebix issued a put option to the each of E-Z Data’s two stockholders. The put option, which expired October 31, 2011, was exercisable during the thirty-day period immediately following the two-year anniversary date of the business acquisition, which if exercised would have enabled them to sell the underlying 1.49 million shares of Ebix common stock they received as part of the purchase consideration, back to the Company at a price of $15.11 per share. At September 30, 2011 the fair value of the put option liability was remeasured and was determined to have increased $893 thousand during the nine month period then ended and with the amount reflected as a loss and is included in other non-operating income (losses) in the accompanying Condensed Consolidated Statement of Income. As of September 30, 2011, the aggregate fair value of this derivative instrument, which is included as in current liabilities in the Condensed Consolidated Balance Sheet, was $1.4 million. The Company has classified the put option, for which the fair value is re-measured on a recurring basis at each reporting date as a Level 2 instrument (i.e. wherein fair is partially determined and based on observable inputs other than quoted market prices), which we believe is the most appropriate level within the fair value hierarchy based on the inputs used to determine its the fair value at the measurement date.